Bull&Bear | Monopar Therapeutics Soars 605%, While Beyond Struggles with 29% Decline

In the realm of soaring stocks, Monopar Therapeutics (MNPR) experienced a remarkable surge, rising 605.40%. The stock price of Monopar Therapeutics doubled, reaching a new level of $10.99.

Another notable performer, Alpha Technology (ATGL), showed a gain of 52.45% and has been on an upward trend for the past two days, resulting in a total increase of 53.66%. Alpha Technology Group announced a new incentive plan aimed at attracting and retaining top talent to further drive the company's innovation and growth. The company stated that this plan would motivate employees through stock options and performance bonuses to achieve long-term goals and maximize shareholder value.

Fortune Source Group (TWG) also witnessed a rise of 42.11% following the release of a favorable foreign issuer report, which positively impacted the stock price.

PureCycle (PCT) gained 29.53%, benefiting from its pioneering advantages and unique recycling technology. Analysts emphasized its expansive initiatives.

QuantumScape (QS) rose by 25.48% after releasing updates on Apple-related cell production, although a third-quarter loss is anticipated.

On the flip side, Beyond (BYON) faced a decline of 29.73%, marking a four-day losing streak with a total drop of 36.41%. Investors' confidence plummeted due to Beyond's poor performance in the third quarter, putting pressure on the stock price.

Community Health (CYH) saw a decrease of 23.42%. A major bank maintained its rating of the community health system as equal weight.

Spirit Airlines (SAVE) experienced a decline of 21.43%. The company estimated that its flight capacity for the fiscal year 2025 would see a mid-double-digit decrease compared to the previous year. Additionally, the third-quarter flight capacity fell by 1.2%, with expectations for the fourth quarter to drop by approximately 20%.

Osisko Development (ODV) dropped by 21.83%, extending a three-day downward trend with a total decrease of 26.22%. The company announced a targeted issuance of units worth $50 million for market promotion.

Icon (ICLR) saw a decline of 21.03%, continuing a four-day drop totaling 25.52%. The downward revision of guidance led to a sell-off in CRO companies, with a brokerage firm downgrading its rating.